:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Weiliang Zhang, Qi Ji, Qingwei Wang, Lixia Liu, Xin Liu, Conglian Qiu, Hui Zhang, Zhizhuo Du, Li Gao, Peifang Xiao, Jing Ling, Liyan Fan, Xinni Bian, Jie Li, Yixin Hu, Bohan Li, Yongping Zhang, Jun Lu, Shuiyan Wu, Jiayue Qin, Shaoyan Hu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Clinical Transplantation
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1111/ctr.70474
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Cidofovir Treatment for Prevention of BK Virus‐Associated Hemorrhagic Cystitis in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
di: Bo Lv, et al.
Pubblicazione: (2025)

Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience
di: Pauline Mazilier, et al.
Pubblicazione: (2025)

The First Phylogenetically Confirmed Hemorrhagic Cystitis Outbreak Among Pediatric Hematopoietic Stem Cell Transplant Recipients
di: Tugba Nukte Tezel, et al.
Pubblicazione: (2025)

The Impact of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Cyclosporine Concentration in Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation
di: Zahra Salehi, et al.
Pubblicazione: (2025)

Stable Expressed DNMT3A Mutants Predict a Poor Prognosis in Acute Myeloid Leukemia Patients Without Receiving Hematopoietic Stem Cell Transplantation
di: Xiang Zhang, et al.
Pubblicazione: (2025)

CSF3R Mutations in Hematological Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
di: Jiaxin Cao, et al.
Pubblicazione: (2025)

X‐Linked Sideroblastic Anemia Caused by ALAS2 Intron 1 Mutation Successfully Treated by Allogenic Hematopoietic Stem Cell Transplant
di: Shurui Du, et al.
Pubblicazione: (2026)

MRD and NK‐Cell Chimerism Predict Transplant Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
di: Xing Chen, et al.
Pubblicazione: (2025)

Adenovirus‐Associated Opsoclonus After Allogeneic Hematopoietic Stem Cell Transplantation
di: Toru Miyajima, et al.
Pubblicazione: (2026)

NUDT21 Drives T‐Cell Acute Lymphoblastic Leukemia Through Dual Regulation of Alternative Polyadenylation and Transcriptional Activation
di: Conglian Qiu, et al.
Pubblicazione: (2026)

Increasing Access to Pediatric Allogeneic Hematopoietic Stem Cell Transplantation in South Africa
di: Candice Laverne Hendricks, et al.
Pubblicazione: (2026)

Venetoclax‐Based Therapy for Early Relapse in Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Minireview
di: Yufeng Du, et al.
Pubblicazione: (2025)

Impact of Preanalytical Sample Preparation on the Recovery Rate of Cryopreserved Allogeneic Hematopoietic Stem Cells
di: Philipp Blüm, et al.
Pubblicazione: (2026)

Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation
di: Nihar Desai, et al.
Pubblicazione: (2024)

VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
di: Eva de Berranger, et al.
Pubblicazione: (2024)

Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
di: Hiroki Hosoi, et al.
Pubblicazione: (2025)

Allogeneic Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma—A Retrospective Multicenter Analysis
di: T. Richardson, et al.
Pubblicazione: (2024)

Model‐Based Prediction of Clinically Relevant Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation
di: Katharina M. Götz, et al.
Pubblicazione: (2025)

Severe HCoV‐OC43 Pneumonia in a 25‐Year‐Old Woman Following Allogeneic Hematopoietic Stem Cell Transplantation
di: Mingzhou Zhang, et al.
Pubblicazione: (2026)

Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Young Adults with Ewing Sarcoma
di: Leardini, Davide
Pubblicazione: (2026)

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With a Germline DDX41 Mutation
di: Shuro Yoshida, et al.
Pubblicazione: (2024)

Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy
di: Mayank Dhamija, et al.
Pubblicazione: (2026)

Efficacy and Safety of Donor Lymphocyte Infusion After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
di: Dinah Walther, et al.
Pubblicazione: (2026)

Effects of HPgV‐1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case‐Control Study
di: Zhanjia Li, et al.
Pubblicazione: (2026)

Physiological Level of Eosinophils Is Essential for the Regeneration and Homeostasis of Murine Hematopoietic Stem Cells
di: Chao Zhang, et al.
Pubblicazione: (2025)

Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
di: Koji Kawamura, et al.
Pubblicazione: (2025)

Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
di: Gabriel Montenegro de Campos, et al.
Pubblicazione: (2025)

A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Severely Underweight Patient with Aplastic Anemia
di: Lilija Banceviča, et al.
Pubblicazione: (2024)

The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation
di: Wenjing Hao, et al.
Pubblicazione: (2026)

Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report
di: Ying He, et al.
Pubblicazione: (2025)

Relapse of Acute Myeloid Leukemia With Concomitant Systemic Mastocytosis Five Years Post Allogenic Hematopoietic Stem Cell Transplantation
di: Sona Vardanyan, et al.
Pubblicazione: (2026)

Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation
di: Rohtesh S. Mehta, et al.
Pubblicazione: (2025)

Utility of Computed Tomography Surveillance of Asymptomatic Infection in Children and Young Adults Before Allogeneic Hematopoietic Stem Cell Transplant
di: Tyler Obermark, et al.
Pubblicazione: (2026)

Clinical and Economic Burden of Cytomegalovirus (CMV) Infection/Disease Among Hospitalized Adult Allogeneic Hematopoietic Stem Cell Transplant (Allo‐HSCT) Recipients in China
di: Chenhua Yan, et al.
Pubblicazione: (2025)

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant
di: George L. Chen, et al.
Pubblicazione: (2026)

Overall Survival in Male Patients With Advanced Hematological Disease (Mostly Acute Leukemia) Is Influenced by CYP1B1 C432G Polymorphism and Donor Sex in Allogeneic Stem Cell Transplantation
di: Norbert Stute, et al.
Pubblicazione: (2024)

Vaccination as a Key Determinant of Influenza Disease Severity in Allogeneic Hematopoietic Stem Cell Transplant Recipients: An Observational Retrospective Study.
di: Martínez-López CI, et al.
Pubblicazione: (2026)

Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective Study
di: Naoki Kurita, et al.
Pubblicazione: (2025)

Varicella‐Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single‐Center Experience of Acyclovir Prophylaxis
di: Galip Arıcı, et al.
Pubblicazione: (2024)

Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation
di: Gin Gin Gan, et al.
Pubblicazione: (2024)